200 related articles for article (PubMed ID: 12642008)
21. Does the treatment of primary hyperaldosteronism influence glucose tolerance?
Strauch B; Widimský J; Sindelka G; Skrha J
Physiol Res; 2003; 52(4):503-6. PubMed ID: 12899664
[TBL] [Abstract][Full Text] [Related]
22. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
[TBL] [Abstract][Full Text] [Related]
23. The effect of adrenal surgery on plasma atrial natriuretic factor and sodium escape phenomenon in patients with primary aldosteronism.
Nakada T; Furuta H; Katayama T; Sumiya H; Shimazaki J
J Urol; 1989 Jul; 142(1):13-8. PubMed ID: 2525199
[TBL] [Abstract][Full Text] [Related]
24. PRIMARY ALDOSTERONISM: OBSERVATIONS IN SIX CASES AND REVIEW OF DIAGNOSTIC PROCEDURES.
LUETSCHER JA
Medicine (Baltimore); 1964 Jul; 43():137-57. PubMed ID: 14183518
[No Abstract] [Full Text] [Related]
25. Correctable subsets of primary aldosteronism. Primary adrenal hyperplasia and renin responsive adenoma.
Irony I; Kater CE; Biglieri EG; Shackleton CH
Am J Hypertens; 1990 Jul; 3(7):576-82. PubMed ID: 2194512
[TBL] [Abstract][Full Text] [Related]
26. Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism.
Boulkroun S; Samson-Couterie B; Dzib JF; Lefebvre H; Louiset E; Amar L; Plouin PF; Lalli E; Jeunemaitre X; Benecke A; Meatchi T; Zennaro MC
Hypertension; 2010 Nov; 56(5):885-92. PubMed ID: 20937967
[TBL] [Abstract][Full Text] [Related]
27. Primary aldosteronism: A common and curable form of hypertension.
Young WF
Cardiol Rev; 1999; 7(4):207-14. PubMed ID: 10423672
[TBL] [Abstract][Full Text] [Related]
28. Primary aldosteronism is comprised of primary adrenal hyperplasia and adenoma.
Biglieri EG; Kater CE; Arteaga EE
J Hypertens Suppl; 1984 Dec; 2(3):S259-61. PubMed ID: 6599673
[TBL] [Abstract][Full Text] [Related]
29. Activation of aldosterone secretion in primary aldosteronism.
Spark RF; Dale SL; Kahn PC; Melby JC
J Clin Invest; 1969 Jan; 48(1):96-104. PubMed ID: 4303791
[TBL] [Abstract][Full Text] [Related]
30. Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma.
Rossi GP; Ragazzo F; Seccia TM; Maniero C; Barisa M; Calò LA; Frigo AC; Fassina A; Pessina AC
Hypertension; 2012 Aug; 60(2):431-6. PubMed ID: 22733469
[TBL] [Abstract][Full Text] [Related]
31. Effect of standard oral glucose loading on aldosterone secretion in primary hyperaldosteronism.
Beretta-Piccoli C; Weidmann P; Brown JJ; Fraser R; Lever AF; Marone C; Robertson JI
Acta Endocrinol (Copenh); 1982 Sep; 101(1):66-71. PubMed ID: 6751010
[TBL] [Abstract][Full Text] [Related]
32. The metabolic syndrome in primary aldosteronism.
Fallo F; Federspil G; Veglio F; Mulatero P
Curr Hypertens Rep; 2007 Apr; 9(2):106-11. PubMed ID: 17442220
[TBL] [Abstract][Full Text] [Related]
33. Primary aldosteronism in childhood due to primary adrenal hyperplasia.
Kikuta Y; Sanjo K; Nakajima K; Ashizawa I; Ojima M
Tohoku J Exp Med; 1988 May; 155(1):57-70. PubMed ID: 3413779
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a test using saralasin to differentiate primary aldosteronism due to an aldosterone-producing adenoma from idiopathic hyperaldosteronism.
Brown RD; Kem DC; Hogan MJ; Hegstad RL
Metabolism; 1984 Aug; 33(8):734-8. PubMed ID: 6748946
[TBL] [Abstract][Full Text] [Related]
35. Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: morphological and functional studies.
Conn JW; Hinerman DL
Metabolism; 1977 Dec; 26(12):1293-307. PubMed ID: 927164
[No Abstract] [Full Text] [Related]
36. Imaging of aldosterone-secreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism.
Rossi GP; Chiesura-Corona M; Tregnaghi A; Zanin L; Perale R; Soattin S; Pelizzo MR; Feltrin GP; Pessina AC
J Hum Hypertens; 1993 Aug; 7(4):357-63. PubMed ID: 8410926
[TBL] [Abstract][Full Text] [Related]
37. Studies of impaired aldosterone response to spironolactone-induced renin and potassium elevations in adenomatous but not hyperplastic primary aldosteronism.
Kater CE; Biglieri EG; Schambelan M; Arteaga E
Hypertension; 1983; 5(6 Pt 3):V115-21. PubMed ID: 6360878
[TBL] [Abstract][Full Text] [Related]
38. Effects of aldosterone on insulin sensitivity and secretion.
Luther JM
Steroids; 2014 Dec; 91():54-60. PubMed ID: 25194457
[TBL] [Abstract][Full Text] [Related]
39. [The localization of aldosterone-producing adenoma on computed tomography--a comparative study with adrenal scintigraphy and plasma aldosterone concentration in the adrenal or renal vein].
Haruyama K; Shigetomi S; Yamazaki M; Toki T; Yaginuma K; Fukuchi S
Nihon Naibunpi Gakkai Zasshi; 1982 Sep; 58(9):1031-9. PubMed ID: 7173453
[TBL] [Abstract][Full Text] [Related]
40. The metabolic syndrome in primary aldosteronism.
Fallo F; Federspil G; Veglio F; Mulatero P
Curr Diab Rep; 2008 Feb; 8(1):42-7. PubMed ID: 18366998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
